The Dermaphenolics Project will investigate the effect of the company’s phenolic compounds on in vitro skin cell cultures, focusing on skin homeostasis and keratinocyte cellular signaling.
These phenolic compounds are currently being studied by Solabia Nutrition in exploratory clinical studies for multiple endpoints, including those related to skin physiology.
“This project is a part of our pipeline of clinical research around skin health parameters and is in line with the trend of consumer interest towards the beauty-from-within category,” a spokesperson for Solabia told us.
The focus on skin health
The project is being co-led by Professor Ellen van den Bogaard, head of the Laboratory for Experimental Dermatology at RUMC, and Yala Stevens, Solabia Nutrition’s head of R&D.
“This [project] is a great first step in understanding the impact that our phenolic lead compounds could have on skin cells and skin homeostasis,” Stevens said. “The Dermophenolics Project will allow us to get mechanistic insights in the area of skin biology and be the basis for further clinical validation.”
A booming segment
According to data from Innova Market Insights, supplements targeting skin health are booming—product launches in the category experienced over 30% average annual growth between 2017 and 2021.
Europe led the region with 41% of nutricosmetic supplement launches during that period, followed by North America with 32%.
The data reveals that botanical and herbal supplements for beauty-from-within saw the biggest growth, accounting for five times more of these supplement launches in 2021 than in 2017. The top formats used for skin health supplements are capsules and tablets, while gummy skin health supplements are also trending.